CAJ | 학술논문

目的观察乌司他丁对吸入性肺炎的治疗作用.方法分析我院2007年1月至2011年6月确诊为吸入性肺炎的住院病例60例,分成对照组和治疗组,治疗组加用乌司他丁,观察两组治疗前后临床症状及临床生化指标改变,以及患者预后情况.结果各组用药前C-反应蛋白(CRP)、白细胞(WBC)、体温、血气分析差异无统计学意义,分组后各组处理结果如下:治疗组与对照组死亡率、治愈率、平均住院时间、CRP、WBC、SaO2、PaO2差异均具有统计学意义(P＜0.05).尤其CRP指标迅速下降.结论吸入性肺炎需尽早诊断、积极治疗、减少或者消除病因、合理用药,降低发病率及病死率.
목적 관찰오사타정대흡입성폐염적치료작용.방법 분석아원2007년1월지2011년6월학진위흡입성폐염적주원병례60례,분성대조조화치료조,치료조가용오사타정,관찰량조치료전후림상증상급림상생화지표개변,이급환자예후정황.결과 각조용약전C-반응단백(CRP)、백세포(WBC)、체온、혈기분석차이무통계학의의,분조후각조처리결과여하:치료조여대조조사망솔、치유솔、평균주원시간、CRP、WBC、SaO2、PaO2차이균구유통계학의의(P＜0.05).우기CRP지표신속하강.결론 흡입성폐염수진조진단、적겁치료、감소혹자소제병인、합리용약,강저발병솔급병사솔.
Objective To observe the effects of ulinastatin on aspiration pneumonia.Methods Sixty patients in our hospital,who were diagnosed as aspiration pneumonia from January 2007 to June 2011,were randomly divided into routine treatment group and ulinastatin treatment group.The ulinastatin treatment group was given ulinastatin in addition.The changes of clinical symptoms and biochemical indexes in two groups were examined before and after treatment.Results There was no statistical difference in C-reactive protein (CRP),white blood cell count (WBC),body temperature and blood gas analysis before treatment between two groups.There was statistical significance in fatality rate,cure rate,the length of average hospital stays,CRP,WBC,SaO2 and PaO2 between treatment group and control group ( P ＜ 0.05).Especially,CRP decreased rapidly.Conclusions It is needed in aspiration pneumonia that early diagnosis,active treatment,inducing or eliminating pathogen,taking medicine properly to reduce morbidity and mortality.